Shots and injection sites
Zepbound Injection Site Reaction Explained
Zepbound and Mounjaro injection site reactions by the label: 6% to 8% vs 2% on placebo for Zepbound, and the warning signs that need a doctor.
Guides

To inject Zepbound, press the single-dose pen flat against clean skin on the abdomen or thigh, unlock it, press the purple button and keep holding until you hear the second click. Lilly's Mounjaro Instructions for Use for the single-dose pen use the same click wording. The Zepbound Instructions for Use say to hold for up to 10 seconds, then check that the gray plunger is visible.
In short
- The Zepbound Instructions for Use say to press and hold the purple button for up to 10 seconds, with the first click meaning the injection has started and the second meaning it has finished.
- The same Instructions for Use say the dose is complete when the gray plunger is visible, that air bubbles are normal, and that you should call 1-800-Lilly-Rx (1-800-545-5979) if the plunger is not visible.
- Lilly's single-dose pen is refrigerated at 36°F to 46°F (2°C to 8°C) and may stay at up to 86°F (30°C) for a total of up to 21 days, while the Mounjaro KwikPen needs a needle and priming.
The steps below follow the order of the Instructions for Use in the US Zepbound and Mounjaro labels for the single-dose pen. Other markets and presentations have their own leaflets, so keep the one from your box open while you inject.
The steps list no measuring, mixing or priming. If anything looks different from your Instructions for Use, follow the leaflet in your box and ask your prescriber or pharmacist.
This guide answers the following questions about the tirzepatide pen, in reading order, using the Instructions for Use and the prescribing information.
Medicine choice, dose and timing are decisions for you and your prescriber. This guide describes only what the labels say about the device.
The Zepbound Instructions for Use tell you to press and hold the purple injection button for up to 10 seconds. You can read the label text in the Zepbound prescribing information on DailyMed.
The first click means the injection has started. The second click means the injection has been completed. Lilly's own how to use Mounjaro page gives the same click wording for the Mounjaro pen.
The first click means the injection has started, not that it has finished, so keep holding until the second click. Then confirm with the plunger.
If you hear only one click, check the plunger and read the next section. The hold time and the click meanings are the same whether the pen is labelled Zepbound or Mounjaro in the Instructions for Use.
The Instructions for Use state that the injection is complete when the gray plunger is visible. If the gray plunger is not visible, the label directs you to call 1-800-Lilly-Rx (1-800-545-5979). That is the number printed for this exact situation.
Your prescriber decides about any further dose. The call to Lilly is the label's step, and your prescriber or pharmacist can help with what follows.
The label ties completion to the gray plunger, so check it after every shot, whether or not the clicks seemed normal.
The Instructions for Use say air bubbles are normal. The label gives no instruction to remove a bubble.
The label's completion check is the two clicks and the gray plunger.
Pressing the pen flat and holding it until the second click is what the label describes. Follow those steps each time.
The Zepbound Instructions for Use name the abdomen or thigh for injecting yourself, and the back of the upper arm if another person gives the shot. Rotate the site each week. You may use the same body area, but choose a different spot within it.
That wording is from the single-dose pen section of the Zepbound prescribing information. Lilly's Mounjaro page repeats the weekly rotation guidance.
A written record makes rotation easy. Note the area and side after each shot, or log it in an app. Then next week's choice is a glance at the last entry.
For the KwikPen, the Lilly Germany guidance says at least 5 cm from the navel for the abdomen.
The label's rule is a different spot each week.
Lilly's KwikPen documents describe a different device from the single-dose pen: you attach a needle and prime the pen. The active ingredient is tirzepatide in both. The single-dose steps in this guide come from the US Zepbound and Mounjaro labels, and other markets and presentations have their own leaflets.
Mounjaro is authorized in the EU, as the EMA Mounjaro page shows. Following a single-dose guide with a KwikPen means missing steps that matter.
KwikPen details from Lilly's own documents:
Use the leaflet in your own box. If it shows a dose knob and a needle you attach, follow the KwikPen leaflet and not the single-dose steps in this guide.
The Instructions for Use say to keep the single-dose pen in the refrigerator at 36°F to 46°F (2°C to 8°C). It may be kept at up to 86°F (30°C) for a total of up to 21 days, then discarded. Both figures come from the Zepbound prescribing information on DailyMed.
The word "total" matters. The 21 days is the sum of all the time out of the fridge, not a fresh 21 days each time you take the pen out. A tally on your calendar is enough to keep track.
Here is an illustrative example. Illustrative figures: if a pen spends 8 days at room temperature on a trip and 5 days on another, the total is 8 + 5 = 13 days. That leaves 21 − 13 = 8 days of the allowance. These numbers are invented to show the sum, not taken from the label.
Your Instructions for Use list the other storage conditions.
If you use a KwikPen, the discard rule is different: 30 days after first use, or after 4 weekly doses, whichever comes first. Do not apply the single-dose pen's 21 days to it.
After the injection, you may wonder when the effect begins. How long Mounjaro takes to reach a steady effect is explained by the label's schedule, and how long a GLP-1 medicine's effect lasts between doses is set out in a week-by-week table. The GLP-1 half-life calculator estimates tirzepatide left in the body from the dose, number of shots and time of the last shot you enter. It never suggests a dose.
The table below lines up the single-dose pen and the Mounjaro KwikPen on needle, priming, site and storage or discard. It does not cover hold time or completion signals for the KwikPen, so use its leaflet for those. The first column comes from the US Zepbound and Mounjaro Instructions for Use. The second comes from the Lilly KwikPen documents cited in the sources.
| Point | Single-dose pen (US Zepbound and Mounjaro labels) | Mounjaro KwikPen |
|---|---|---|
| Needle | No needle to attach | Attached by you |
| Priming | No priming step in the Instructions for Use | Turn to priming position (2 clicks), push dose knob to the stop, count slowly to 5 |
| Abdomen site | Abdomen or thigh for self-injection | At least 5 cm from the navel |
| Storage and discard | Refrigerator at 36°F to 46°F (2°C to 8°C); up to 86°F (30°C) for a total of up to 21 days, then discard | Discard 30 days after first use or after 4 weekly doses, whichever comes first. Storage rules can differ by market, so follow your leaflet |
Read the table by the pen in your hand. Both devices deliver tirzepatide once a week, but they ask you to do different things. For hold time, clicks and the completion check on the single-dose pen, see the sections above.
The label also gives weekly rules that apply either way, quoted here from Lilly's patient page. Leave at least 3 days (72 hours) between doses if you change your dose day. A missed dose can be taken within 4 days (96 hours), and beyond that it is skipped and the regular day resumes. Never take two doses within 3 days of each other. Your prescriber decides what applies to you.
The mistakes below are the ones the label wording points to, from letting go early to mixing up devices. None of them is a dosing instruction.
A fifth habit is worth adding, though it is not a label rule: record the site every week. A log turns rotation into a glance at the last entry.
Contact your prescriber or pharmacist for any injection problem the leaflet does not cover, and seek emergency care for severe symptoms of the serious side effects named in the Zepbound Medication Guide. The guide is part of the Zepbound prescribing information on DailyMed.
The Medication Guide lists these serious side effects, with the signs to watch for:
Read the full wording in your own Medication Guide, because it describes each sign in more detail.
Common reactions are listed separately. The Zepbound label reports nausea in 25%, 29% and 28% of people on 5 mg, 10 mg and 15 mg over 72 weeks, against 8% on placebo. The Mounjaro label, in type 2 diabetes, reports nausea in 12%, 15% and 18% on the same three doses against 4% on placebo. The two figures come from different populations and indications, so they are not a ranking.
Dose & Lose is a GLP-1 companion app for iPhone and Android that logs each dose with the medication, the dose, the date and time, the injection site, a pain level from 0 to 10 and notes. It is a tracking app. It does not prescribe, supply or give dosing advice.
With rotation turned on, the app remembers where the last injection went and suggests the next site on the other side. It suggests, and you choose. You can also set a reminder time and get a notification on dose days.
It also draws an estimate of how much medication is active from the doses you log. That is an estimate from a fixed model, not a lab value.
See the Dose & Lose app page. The app's interface is in English only. Logging doses, side effects, water, weight and food is free.
Call 1-800-Lilly-Rx (1-800-545-5979). The Instructions for Use say the injection is complete when the gray plunger is visible, and they tell you to call if it is not. Your prescriber decides about any further dose, so tell them what happened.
In the US labels, the single-dose pen instructions use the same click wording, and both medicines contain tirzepatide. Other markets and presentations, such as the Mounjaro KwikPen, have their own leaflets with a needle and priming steps. Follow the Instructions for Use that came with your pen.
The steps in this guide do not include pinching. You press the single-dose pen flat against clean skin, unlock it and press the button. If your Instructions for Use or your prescriber describes a different technique for your pen, follow that, because the leaflet in your box is the final authority.
Yes. The Zepbound Instructions for Use name the back of the upper arm as a site when another person gives the injection. When you inject yourself, the label names the abdomen or thigh. The helper follows the same steps: pen flat, unlock, hold until the second click, check the plunger.
No. The Instructions for Use say air bubbles are normal. Judge the dose by the two clicks and the visible gray plunger. If the plunger is not visible, call 1-800-Lilly-Rx (1-800-545-5979) as the label directs, and let your prescriber decide about anything further.
Every figure in this guide comes from the labels and Lilly pages below. Each link goes to the record itself.
Published by Petros IT Solutions SRL, byline Dose & Lose Editorial Team. This guide is educational and is not personal medical advice. To report an error, write to office@doseandlose.com.